Loss of function mutations in either ALK1 (HHT type 1) or ENG (HHT type 2) are the most common and occur in over 85% HHT cases, while the other two gene mutations are relatively rare. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.